Coronavirus Antigen Testing Gets Green Light In Germany
Boost for testing volumes and Paul-Ehrlich-Institut role gets industry support
Germany is adjusting the national COVID-19 testing strategy, which from mid-October will include the use of antigen tests.
You may also be interested in...
Cue’s point-of-care molecular test earned an FDA emergency use authorization in June.
With daily German COVID-19 infection levels refusing to decline, testing labs are urging the health ministry to take some of the pressure off them.
German reimbursement of COVID-19 confirmatory tests has been reduced by one third, a decision that has frustrated both the testing labs and the diagnostics manufacturers who jointly provided the basis of the system that kept the coronavirus to within manageable proportions nationally.